## Abstract Quantitative evaluation of brain magnetic resonance imaging (MRI) scans is now an accepted part of the trial of new putative treatments for multiple sclerosis (MS). However, conventional MRI is not pathologically specific, and it does not reveal the details of the pathological processes
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis
✍ Scribed by Dr M. Filippi; M. A. Horsfield; H. J. Adèr; F. Barkhof; P. Bruzzi; A. Evans; J. A. Frank; R. I. Grossman; H. F. McFarland; P. Molyneux; D. W. Paty; J. Simon; P. S. Tofts; J. S. Wolinsky; D. H. Miller
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 871 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Magnetic resonance imaging (MRI) has been widely used to diagnose and monitor multiple sclerosis (MS). Although MRI‐visible lesions are a key feature of MS, they are thought to correlate poorly with clinical progression. Neurodegeneration is increasingly being recognized as an important
Copyright 0 1995 by the American Neurological Association 749 tected when using conventional MRI scans of standard slice thickness.
Magnetic resonance imaging (MRI) has been shown in a number of studies to be a very sensitive method for detecting focal areas of damage in the white matter of the cerebral hemispheres. This sensitivity has been reflected in the wave of enthusiasm with which MRI has been used in the diagnostic evalu